| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biomarkers in oncology drug development
|
Hodgson, Darren R.
|
|
2009
|
3 |
1 |
p. 24-32
9 p.
|
artikel
|
| 2 |
Conference calendar
|
|
|
2009
|
3 |
1 |
p. 84-85
2 p.
|
artikel
|
| 3 |
Ebselen abrogates TNFα induced pro-inflammatory response in glioblastoma
|
Tewari, Richa
|
|
2009
|
3 |
1 |
p. 77-83
7 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2009
|
3 |
1 |
p. ii-
1 p.
|
artikel
|
| 5 |
Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells
|
Emara, Marwan
|
|
2009
|
3 |
1 |
p. 45-53
9 p.
|
artikel
|
| 6 |
HBx genotype D represses GSTP1 expression and increases the oxidative level and apoptosis in HepG2 cells
|
Niu, Dandan
|
|
2009
|
3 |
1 |
p. 67-76
10 p.
|
artikel
|
| 7 |
PCDH24-induced contact inhibition involves downregulation of β-catenin signaling
|
Ose, Rui
|
|
2009
|
3 |
1 |
p. 54-66
13 p.
|
artikel
|
| 8 |
Personal Profiles
|
|
|
2009
|
3 |
1 |
p. 1-2
2 p.
|
artikel
|
| 9 |
Profile: Professor Axel Ullrich
|
Cheng, Margaret Harris
|
|
2009
|
3 |
1 |
p. 3-4
2 p.
|
artikel
|
| 10 |
Report on EU–USA Workshop: How Systems Biology Can Advance Cancer Research (27 October 2008)
|
Aebersold, Ruedi
|
|
2009
|
3 |
1 |
p. 9-17
9 p.
|
artikel
|
| 11 |
‘Tackling cancer in the EU: The role of innovation’
|
Andrejevs, Georgs
|
|
2009
|
3 |
1 |
p. 18-23
6 p.
|
artikel
|
| 12 |
Targeted proteomic strategy for clinical biomarker discovery
|
Schiess, Ralph
|
|
2009
|
3 |
1 |
p. 33-44
12 p.
|
artikel
|
| 13 |
Turning the Stockholm Declaration into reality: Creating a world-class infrastructure for cancer research in Europe
|
Brown, Hannah
|
|
2009
|
3 |
1 |
p. 5-8
4 p.
|
artikel
|
Tijdschrift beschrijving